P. 1
Personalized Medicine Diagnostics Market

Personalized Medicine Diagnostics Market

Views: 6|Likes:
Published by donnayoung5
The report contains over 125 pages of solid market analysis, which puts the concept of personalized medicine into terms that business planners can understand. What products are on the market earning revenues today?
The report contains over 125 pages of solid market analysis, which puts the concept of personalized medicine into terms that business planners can understand. What products are on the market earning revenues today?

More info:

Published by: donnayoung5 on Mar 01, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

05/13/2014

pdf

text

original

World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing

) A special focus of the report is the bustle of activity with collaborations between IVD and pharmaceutical companies, as well as IVD companies and CLIA labs. This report profiles scores of such companies operating in this market and estimates and forecasts markets (where there are products on the market) for personalized medicine technologies in the following categories:                  Cardiac Markers, immunoassays Cardiac Risk Markers Cardiac markers, molecular Coagulation, routine Coagulation, molecular Cancer, Tumor Markers Cancer, Molecular Cancer, Tissue-based Psychiatric Disorders Diabetes, BGM Diabetes, HbA1c Microbiology, ID/AST Infectious Diseases, Viral Load (HIV, HCV, HBV) Infectious Diseases, other Blood Bank Molecular Transplant Tissue Typing Lab Developed Tests

Request a Sample for or Inquire before buying the report Personalized Medicine Diagnostics Market In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. Developments that are linked in the press to 'personalized medicine' are many, and can at times be confusing. But there are several discovered biomarkers that are important in diagnostic markets. Biomarkers discussed in the report include:       Cytochrome P450 and Drug Metabolism Estrogen Receptor and Progesterone Receptor Status for Breast Cancer HER2 Overexpression and Herceptin and Tykerb Epidermal Growth Factor Receptor (EGFR) KRAS Mutations and Anti-EGFR Therapy for Colorectal Cancer

     

BRAF Mutations and Cancer Therapy UGT1A1 Genetic Variants 5-Flurouracil Therapy PIK3CA Genetic Variation KIF6 Genetic Variation ALK Genetic Variation

Major points covered in Table of Contents of this report include:          CHAPTER ONE: EXECUTIVE SUMMARY CHAPTER TWO: INTRODUCTION CHAPTER THREE: STRATEGIC ISSUES: THE “COMMERCIALIZATION CONDUNDRUM” CHAPTER FOUR: DISEASE TARGETS CHAPTER FIVE: DIAGNOSTIC TECHNOLOGIES CHAPTER SIX: MARKET ANALYSIS CHAPTER SEVEN: CONCLUSIONS AND STRATEGIC IMPLICATIONS CHAPTER EIGHT: COMPANY PROFILES List of Tables

Explore Reports related to Biotechnology @ http://www.reportsnreports.com/marketresearch/biotechnology/ Report Details: Published: March 2012 No. of Pages: 430 Price: Single User License – US$3795

Corporate User License – US$7590

Contact: Priyank Tiwari 7557 Rambler road, Suite 727, Dallas, TX 75231 Tel: +1-888-391-5441 sales@reportsandreports.com Visit our Market Research Blog @ http://www.reportsnreportsblog.com/ Connect With Us:

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->